Delapril and Manidipine Main Degradation Products: LC-UV and LC-ESI-MS Evaluations, Decay Kinetic, and in vitro Cytotoxicity Studies

References

• Onoyama, K.; Nanishi, F.; Okuda, S.; Oh, Y.; Fujishima, M.; Tateno, M.; Omae, T. Pharmacokinetics of a New Angiotensin I Converting Enzyme Inhibitor (Delapril) in Patients with Deteriorated Kidney Function and in Normal Control Subjects. Clin. Pharmacol. Ther. 1988, 43, 242–249.
   PubMed Web of Science ®Google Scholar
• Iimura, O.; Shimamoto, K. Efficacy and Mode of Action of Manidipine: A New Calcium Antagonist. Am. Heart J. 1993, 125, 635–641.
   PubMed Web of Science ®Google Scholar
• Otero, M. L. Manidipine-Delapril Combination in the Management of Hypertension. Vas. Health Risk Manag. 2007, 3, 255–263.
   PubMedGoogle Scholar
• McCormack, P. L.; Keating, G. M. Delapril/Manidipine. Drugs 2006, 66, 961–969.
   PubMed Web of Science ®Google Scholar
• Todeschini, V.; Sangoi, M.; Volpato, N. M. Delapril and Manidipine Measurements by Liquid Chromatography-Tandem Mass Spectrometry in Pharmaceutical Formulation. Eur. J. Mass Spectrom. 2011, 17, 287–296.
   PubMed Web of Science ®Google Scholar
• Todeschini, V.; Meira, A. S.; Sangoi, M. S.; Barth, A. B.; Paim, C. S.; Volpato, N. M. Simultaneous Determination of Delapril and Manidipine in a Pharmaceutical Formulation by a Stability-Indicating RP-LC Method. J. Liq. Chromatogr. Related Technol. 2012, 35, 603–620.
   Web of Science ®Google Scholar
• Todeschini, V.; Meira, A. S.; Sangoi, M. S.; Miron, D.; Lange, A. D.; Volpato, N. M. Stability-Indicating Micellar Electrokinetic Chromatography Technique for Simultaneous Measurement of Delapril and Manidipine from their Combination Drug Formulation. J. AOAC Int. 2014, 97, 114–120.
   PubMed Web of Science ®Google Scholar
• Basak, A. K.; Raw, A. S.; Al Hakim, A. H.; Furness, S.; Samaan, N. I.; Gill, D. S.; Patel, H. B.; Powers, R. F.; Yu, L. Pharmaceutical Impurities: Regulatory Perspective for Abbreviated New Drug Applications. Adv. Drug Deliv. Rev. 2007, 59, 64–72.
   PubMed Web of Science ®Google Scholar
• Ahuja, S. Assuring Quality of Drugs by Monitoring Impurities. Adv. Drug Deliv. Rev. 2007, 59, 3–11.
   PubMed Web of Science ®Google Scholar
• ICH Guidelines. Q1A (R2): Stability Q5 Testing of New Drug Substances and Products, in: International Conference on Harmonisation, Geneva, Switzerland, 2003.
   Google Scholar
• Fukutsu, N.; Kawasaki, T.; Saito, K.; Nakazawa, H. Application of High-Performance Liquid Chromatography Hyphenated Techniques for Identification of Degradation Products of Cefpodoxime Proxetil. J. Chromatogr. A. 2006, 1129, 153–159.
   PubMed Web of Science ®Google Scholar
• Mehta, S.; Shah, R. P.; Singh, S. Strategy for Identification and Characterization of Small Quantities of Drug Degradation Products using LC and LC-MS: Application to Valsartan, a Model Drug. Drug Test Anal. 2010, 2, 82–90.
   PubMed Web of Science ®Google Scholar
• Volk, K. J.; Hill, S. E.; Kerns, E. H.; Lee, M. S. Profiling Degradants of Paclitaxel using Liquid Chromatography Mass Spectrometry and Liquid Chromatography Tandem Mass Spectrometry Substructural Techniques. J. Chromatogr. B. 1997, 696, 99–115.
   PubMed Web of Science ®Google Scholar
• ICH Guidelines. Q2 (R1): Validation of analytical procedures: text and methodology, in: International Conference on Harmonisation, Geneva, Switzerland, 2005.
   Google Scholar
• Shabir, G. A. Validation of High-Performance Liquid Chromatography Methods for Pharmaceutical Analysis Understanding the Differences and Similarities Between Validation Requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization. J. Chromatogr. A. 2003, 987, 57–60.
   PubMed Web of Science ®Google Scholar
• Heyden, Y. V.; Nijhuis, A.; Smeyers-Verbeke, J.; Vandeginste, B. G. M.; Massart, D. L. Guidance for Robustness/Ruggedness Tests in Method Validation. J. Pharm. Biomed. Anal. 2001, 24, 723–753.
   PubMed Web of Science ®Google Scholar
• Vanaja, K.; Rani, R. H. S. Design of Experiments: Concept and Applications of Placket Burman Design. Clin. Res. Regul. Aff. 2007, 24, 1–23.
   Google Scholar
• Baertschi, S. W.; Jansen, P. J. Pharmaceutical Stress Testing: Predicting Drug Degradation. Taylor & Francis Group: Boca Raton, 2005.
   Google Scholar
• Bakshi, M.; Singh, S. Development of Validated Stability-Indicating Assay Methods – Critical Review. J. Pharm. Biomed. Anal. 2002, 28, 1011–1040.
   PubMed Web of Science ®Google Scholar
• Sangoi, M. S.; Todeschini, V.; Steppe, M. Fesoterodine Stress Degradation Behavior by Liquid Chromatography Coupled to Ultraviolet Detection and Electrospray Ionization Mass Spectrometry. Talanta 2011, 84, 1068–1079.
   PubMed Web of Science ®Google Scholar
• Shionoiri, M. D. H.; Yasuda, M. D. G.; Ikeda, A. M. D.; Ohta, M. D. T.; Miyajima, M. D. E.; Kaneko, M. D. Y. Pharmacokinetics and Depressor Effect of Delapril in Patients with Essential Hypertension. Clin. Pharmacol. Ther. 1987, 41, 74–79.
   PubMed Web of Science ®Google Scholar
• Albini, A.; Fasani, E. Photochemistry of Drugs: An Overview and Practical Problems. In Drugs: Photochemistry and Photostability; Albini, A. Fasani, E. Eds.; MPG Books Ltd: Bodmin, 1998.
   Google Scholar
• Albini, A.; Fasani, E. Rationalizing the Photochemistry of Drugs. In Photostability of Drugs and Drug Formulations, 2nd ed.; Tønnesen, H. H. Ed.; CRC Press: Boca Raton, 2004.
   Google Scholar
• Morimoto, S.; Matsumura, Y. Manidipine Hydrochloride [CV-4093(2HCl)]. Cardiovasc. Drug. Rev. 1991, 9, 201–222.
   Web of Science ®Google Scholar
• Mielcarek, J.; Szamburska, O. Inclusion Complexes of Manidipine with c-Cyclodextrin and Identification of Photodegradation Products. J. Incl. Phen. Macro. Chem. 2005, 52, 195–200.
   Web of Science ®Google Scholar
• Waterman, K. C. Understanding and Predicting Pharmaceutical Product Shelf-Life. In Handbook of Stability Testing in Pharmaceutical Development: Regulations, Methodologies, and Best Practices. Huynh-Ba, K. Ed.; Springer: New York, 2009.
   Google Scholar
• Nudelman, N. S. Estabilidad de Medicamentos; El Ateneo: Buenos Aires, 1975.
   Google Scholar
• Martinez, V.; Corsini, E.; Mitjans, M.; Pinazo, A.; Vinardell, M. P. Evaluation of Eye and Skin Irritation of Arginine-Derivative Surfactants using Different in vitro Endpoints as Alternatives to the in vivo Assays. Toxicol. Lett. 2006, 164, 259–267.
   PubMed Web of Science ®Google Scholar
• Paim, C. S.; Führ, F.; Barth, A. B.; Gonçalves, C. E. I.; Nardi, N.; Steppe, M.; Schapoval, E. E. S. Gemifloxacin Mesylate (GFM) Stability Evaluation Applying a Validated Bioassay Method and in vitro Cytotoxic Study. Talanta 2011, 83, 1774–1779.
   PubMed Web of Science ®Google Scholar
• Malesuik, M. D.; Gonçalves, H. M. L.; Garcia, C. V.; Trein, M. R.; Nardi, N. B.; Schapoval, E. E. S.; Steppe, M. Identification, Characterization and Cytotoxicity in vitro Assay of Nitazoxanide Major Degradation Product. Talanta 2012, 93, 206–211.
   PubMed Web of Science ®Google Scholar